Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D
April 25, 2019

Abaloparatide followed by alendronate treatment may improve bone mineral density (BMD) in women with postmenopausal osteoporosis and type 2 diabetes (T2D), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.